issues with glp 1 drugs GLP-1 nausea: How to handle GLP-1s' most common side effect GLP-1 Drugs: 6 Things We've

H.CaoiliE

[DOI] [PubMed] [Google Scholar] 57.Blech S., Ludwig-Schwellinger E., Grfe-Mody E.U., Withopf B., Wagner K

If approved, Wegovy will become the first oral GLP-1 indicated for chronic weight management

Seek immediate medical attention for warning signs including: severe or persistent vomiting, inability to keep fluids down for more than 24 hours, severe abdominal pain (especially if radiating to the back), abdominal distension with absence of stool or gas, or yellowing of the skin/eyes with right upper abdominal pain

Cardiovascular risk reduction seems however to be more pronounced in individuals with T2DM and established atherosclerotic cardiovascular disease (ASCVD) as compared to those without established ASCVD [5]